Literature DB >> 28031331

Activation-Dependent TRAF3 Exon 8 Alternative Splicing Is Controlled by CELF2 and hnRNP C Binding to an Upstream Intronic Element.

Astrid-Solveig Schultz1, Marco Preussner1, Mario Bunse2, Rotem Karni3, Florian Heyd4.   

Abstract

Cell-type-specific and inducible alternative splicing has a fundamental impact on regulating gene expression and cellular function in a variety of settings, including activation and differentiation. We have recently shown that activation-induced skipping of TRAF3 exon 8 activates noncanonical NF-κB signaling upon T cell stimulation, but the regulatory basis for this splicing event remains unknown. Here we identify cis- and trans-regulatory elements rendering this splicing switch activation dependent and cell type specific. The cis-acting element is located 340 to 440 nucleotides upstream of the regulated exon and acts in a distance-dependent manner, since altering the location reduces its activity. A small interfering RNA screen, followed by cross-link immunoprecipitation and mutational analyses, identified CELF2 and hnRNP C as trans-acting factors that directly bind the regulatory sequence and together mediate increased exon skipping in activated T cells. CELF2 expression levels correlate with TRAF3 exon skipping in several model systems, suggesting that CELF2 is the decisive factor, with hnRNP C being necessary but not sufficient. These data suggest an interplay between CELF2 and hnRNP C as the mechanistic basis for activation-dependent alternative splicing of TRAF3 exon 8 and additional exons and uncover an intronic splicing silencer whose full activity depends on the precise location more than 300 nucleotides upstream of the regulated exon.
Copyright © 2017 American Society for Microbiology.

Entities:  

Keywords:  RNA binding proteins; RNA splicing

Mesh:

Substances:

Year:  2017        PMID: 28031331      PMCID: PMC5359431          DOI: 10.1128/MCB.00488-16

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  47 in total

1.  Nova regulates brain-specific splicing to shape the synapse.

Authors:  Jernej Ule; Aljaz Ule; Joanna Spencer; Alan Williams; Jing-Shan Hu; Melissa Cline; Hui Wang; Tyson Clark; Claire Fraser; Matteo Ruggiu; Barry R Zeeberg; David Kane; John N Weinstein; John Blume; Robert B Darnell
Journal:  Nat Genet       Date:  2005-07-24       Impact factor: 38.330

2.  Auxiliary splice factor U2AF26 and transcription factor Gfi1 cooperate directly in regulating CD45 alternative splicing.

Authors:  Florian Heyd; Gerdy ten Dam; Tarik Möröy
Journal:  Nat Immunol       Date:  2006-07-02       Impact factor: 25.606

3.  An alternative splicing switch regulates embryonic stem cell pluripotency and reprogramming.

Authors:  Mathieu Gabut; Payman Samavarchi-Tehrani; Xinchen Wang; Valentina Slobodeniuc; Dave O'Hanlon; Hoon-Ki Sung; Manuel Alvarez; Shaheynoor Talukder; Qun Pan; Esteban O Mazzoni; Stephane Nedelec; Hynek Wichterle; Knut Woltjen; Timothy R Hughes; Peter W Zandstra; Andras Nagy; Jeffrey L Wrana; Benjamin J Blencowe
Journal:  Cell       Date:  2011-09-15       Impact factor: 41.582

4.  Conserved proline-directed phosphorylation regulates SR protein conformation and splicing function.

Authors:  Malik M Keshwani; Brandon E Aubol; Laurent Fattet; Chen-Ting Ma; Jinsong Qiu; Patricia A Jennings; Xiang-Dong Fu; Joseph A Adams
Journal:  Biochem J       Date:  2015-03-01       Impact factor: 3.857

5.  Phosphorylation-dependent regulation of PSF by GSK3 controls CD45 alternative splicing.

Authors:  Florian Heyd; Kristen W Lynch
Journal:  Mol Cell       Date:  2010-10-08       Impact factor: 17.970

6.  SR protein kinases promote splicing of nonconsensus introns.

Authors:  Jesse J Lipp; Michael C Marvin; Kevan M Shokat; Christine Guthrie
Journal:  Nat Struct Mol Biol       Date:  2015-07-13       Impact factor: 15.369

7.  A postnatal switch of CELF and MBNL proteins reprograms alternative splicing in the developing heart.

Authors:  Auinash Kalsotra; Xinshu Xiao; Amanda J Ward; John C Castle; Jason M Johnson; Christopher B Burge; Thomas A Cooper
Journal:  Proc Natl Acad Sci U S A       Date:  2008-12-15       Impact factor: 11.205

8.  The epithelial splicing factors ESRP1 and ESRP2 positively and negatively regulate diverse types of alternative splicing events.

Authors:  Claude C Warzecha; Shihao Shen; Yi Xing; Russ P Carstens
Journal:  RNA Biol       Date:  2009-11-22       Impact factor: 4.652

9.  Diversity and conservation of CELF1 and CELF2 RNA and protein expression patterns during embryonic development.

Authors:  Y Blech-Hermoni; S J Stillwagon; A N Ladd
Journal:  Dev Dyn       Date:  2013-04-15       Impact factor: 3.780

10.  Position-dependent activity of CELF2 in the regulation of splicing and implications for signal-responsive regulation in T cells.

Authors:  Sandya Ajith; Matthew R Gazzara; Brian S Cole; Ganesh Shankarling; Nicole M Martinez; Michael J Mallory; Kristen W Lynch
Journal:  RNA Biol       Date:  2016-04-20       Impact factor: 4.652

View more
  9 in total

1.  Characterization of cis-acting elements that control oscillating alternative splicing.

Authors:  Gesine Goldammer; Alexander Neumann; Miriam Strauch; Michaela Müller-McNicoll; Florian Heyd; Marco Preußner
Journal:  RNA Biol       Date:  2018-09-10       Impact factor: 4.652

2.  Alternative Splicing of the Aryl Hydrocarbon Receptor Nuclear Translocator (ARNT) Is Regulated by RBFOX2 in Lymphoid Malignancies.

Authors:  Amy M Cooper; Curtis A Nutter; Muge N Kuyumcu-Martinez; Casey W Wright
Journal:  Mol Cell Biol       Date:  2022-04-11       Impact factor: 5.069

3.  The zinc finger domains in U2AF26 and U2AF35 have diverse functionalities including a role in controlling translation.

Authors:  Olga Herdt; Stefan Reich; Jan Medenbach; Bernd Timmermann; Didrik Olofsson; Marco Preußner; Florian Heyd
Journal:  RNA Biol       Date:  2020-03-01       Impact factor: 4.652

Review 4.  The First Orally Deliverable Small Molecule for the Treatment of Spinal Muscular Atrophy.

Authors:  Ravindra N Singh; Eric W Ottesen; Natalia N Singh
Journal:  Neurosci Insights       Date:  2020-11-23

Review 5.  CELF Family Proteins in Cancer: Highlights on the RNA-Binding Protein/Noncoding RNA Regulatory Axis.

Authors:  Maryam Nasiri-Aghdam; Texali C Garcia-Garduño; Luis Felipe Jave-Suárez
Journal:  Int J Mol Sci       Date:  2021-10-14       Impact factor: 5.923

6.  The cancer-associated U2AF35 470A>G (Q157R) mutation creates an in-frame alternative 5' splice site that impacts splicing regulation in Q157R patients.

Authors:  Olga Herdt; Alexander Neumann; Bernd Timmermann; Florian Heyd
Journal:  RNA       Date:  2017-09-11       Impact factor: 4.942

7.  Reciprocal regulation of hnRNP C and CELF2 through translation and transcription tunes splicing activity in T cells.

Authors:  Michael J Mallory; Sean P McClory; Rakesh Chatrikhi; Matthew R Gazzara; Robert J Ontiveros; Kristen W Lynch
Journal:  Nucleic Acids Res       Date:  2020-06-04       Impact factor: 16.971

8.  CELF2 regulates the species-specific alternative splicing of TREM2.

Authors:  Motoaki Yanaizu; Chika Washizu; Nobuyuki Nukina; Jun-Ichi Satoh; Yoshihiro Kino
Journal:  Sci Rep       Date:  2020-10-22       Impact factor: 4.379

Review 9.  Role of Alternative Splicing in Regulating Host Response to Viral Infection.

Authors:  Kuo-Chieh Liao; Mariano A Garcia-Blanco
Journal:  Cells       Date:  2021-07-08       Impact factor: 6.600

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.